IRIS
DEL PRETE, MICHELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.425
EU - Europa 638
AS - Asia 242
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.357
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.425
IT - Italia 143
UA - Ucraina 142
SE - Svezia 89
TR - Turchia 83
IE - Irlanda 73
CN - Cina 68
DE - Germania 63
DK - Danimarca 56
SG - Singapore 51
FI - Finlandia 41
CI - Costa d'Avorio 30
KR - Corea 30
MA - Marocco 18
GB - Regno Unito 14
IN - India 8
BE - Belgio 7
FR - Francia 4
DZ - Algeria 3
NL - Olanda 3
JP - Giappone 2
CZ - Repubblica Ceca 1
EU - Europa 1
HR - Croazia 1
RO - Romania 1
Totale 2.357
Salva come PNG Salva come JPEG
Città #
Chandler 194
Fairfield 150
Jacksonville 150
Ashburn 96
Wilmington 86
Boardman 81
Dublin 73
New York 68
Seattle 65
Woodbridge 65
Ann Arbor 64
Houston 50
Centro 49
Cambridge 34
Turin 32
Lawrence 31
Princeton 31
San Mateo 31
Abidjan 30
Des Moines 19
San Diego 14
Helsinki 13
Singapore 13
Beijing 12
Pune 8
Brussels 6
Izmir 6
London 6
Los Angeles 6
Shanghai 5
Wuhan 5
Washington 4
Amsterdam 3
Dallas 3
Fermignano 3
Guangzhou 3
Kilburn 3
Norwalk 3
Wuxi 3
Como 2
Florence 2
Foshan 2
Isola della Scala 2
Kagoya 2
Milan 2
Modena 2
Montesilvano 2
New Bedfont 2
Roseto degli Abruzzi 2
Shenzhen 2
Venice 2
Yiwu 2
Acerra 1
Ascoli Piceno 1
Chicago 1
Chiswick 1
Clifton 1
Dalian 1
Dongyang 1
Falconara Marittima 1
Falkenstein 1
Frankfurt (Oder) 1
Hanover 1
Heze 1
Hounslow 1
Jinhua 1
Matelica 1
Nantong 1
Olomouc 1
Pesaro 1
Qingdao 1
Santa Clara 1
Seoul 1
Stamford 1
Suzhou 1
Tiantai Chengguanzhen 1
Torre Del Greco 1
Waterloo 1
Totale 1.570
Salva come PNG Salva come JPEG
Nome #
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 129
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 118
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 117
Optimal management of resected gastric cancer 100
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment 96
Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: A multicentric retrospective analysis 89
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 85
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 83
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 83
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 81
Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: Are all mutations equal? 80
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 78
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 78
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 75
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 73
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab 72
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 70
Novel perspectives for the treatment of gastric cancer: From a global approach to a personalized strategy 69
Panitumumab for the treatment of metastatic colorectal cancer: A review 69
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 69
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 69
Trattamento del carcinoma del pancreas. Attualità e prospettive 68
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer 68
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 65
Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients 65
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 65
Gastric cancer: Therapeutic choices in advanced disease 64
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 59
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 56
The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy 55
Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: It is not about the destination, it is about the journey 55
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients 27
Totale 2.430
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.105
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020182 0 1 25 1 30 0 33 5 31 5 7 44
2020/2021527 33 53 55 5 101 19 33 33 43 80 50 22
2021/2022266 28 58 7 5 2 18 13 18 12 39 18 48
2022/2023560 40 76 45 43 36 74 1 35 130 6 63 11
2023/2024317 48 6 28 38 33 104 4 5 1 6 2 42
2024/2025153 99 54 0 0 0 0 0 0 0 0 0 0
Totale 2.430